Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier

Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier

Atractylodes lancea (Thunb.) DC. (AL) is used in traditional Chinese medicine for the treatment of spleen-deficiency syndrome (SDS). Bran-processed Atractylodes lancea (BAL) has been found to be more effective than unprocessed AL. However, the compound in BAL active against SDS remains unclear. The...

Full description

Bibliographic Details
Main Authors: Jiyuan Tu, Ying Xie, Kang Xu, Linghang Qu, Xiong Lin, Chang Ke, Desen Yang, Guosheng Cao, Zhongshi Zhou, Yanju Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
spleen-deficiency syndrome
Atractyloside A
network pharmacology
intestinal mucosal barrier
p38 MAPK
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.583160/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.583160/full

Similar Items